Pfizer Chief to Visit Ann Arbor Facility Targeted for Closing

By  | 

Pfizer Inc.'s chief executive planned to visit a research facility that is being closed as part of the drug maker's restructuring, costing about 2,100 jobs.

Jeffrey Kindler, who became Pfizer's CEO last summer and chairman in December, was to encourage employees to stay with the New York drug maker during Wednesday's visit, said Rick Chambers, a Pfizer spokesman in Michigan.

Pfizer has said it planned to transfer up to 70 percent of the Ann Arbor employees to other company locations.

"It's important to him to spend time with colleagues, and that's the main purpose of the visit," Chambers said.

Chambers said Kindler wouldn't be available to media during the visit and declined to detail the timing of the visit.

The world's largest drug maker announced Jan. 22 that it planned to shut down facilities in Ann Arbor, Kalamazoo and suburban Detroit, affecting about 2,410 Michigan jobs by the end of 2008. All but about 310 of those jobs are in the Ann Arbor area.

The closings in Michigan are part of a company wide plan to cut 10,000 jobs and shut down at least five facilities.